Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To determine whether the presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to familial Alzheimer's disease (FAD) increase the extracellular concentration of amyloid beta-protein (A beta) ending at A beta 42(43) in vivo, we performed a blinded comparison of plasma A beta levels in carriers of these mutations and controls. A beta 1-42(43) was elevated in plasma from subjects with FAD-linked PS1 (P < 0.0001), PS2N1411 (P = 0.009), APPK670N,M671L (P < 0.0001), and APPV7171 (one subject) mutations. A beta ending at A beta 42(43) was also significantly elevated in fibroblast media from subjects with PS1 (P < 0.0001) or PS2 (P = 0.03) mutations. These findings indicate that the FAD-linked mutations may all cause Alzhelmer's disease by increasing the extracellular concentration of A beta 42(43), thereby fostering cerebral deposition of this highly amyloidogenic peptide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [11]
In the citing paper
“Similar to PSEN1 , PSEN2 mutations may also cause increased production of long A 𝛃 peptide species (481, 523), although this needs more investigation.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [523]
In the citing paper
“It is well established that this mutation causes concomitant increases in secreted A42 and A40 (Cai et al., 1993;Citron et al., 1994;Scheuner et al., 1996).”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
In the citing paper
“In a previous study of human plasma (Scheuner et al., 1996), we showed that the Swedish APP K670N,M671L mutation increases both A42 and A40 and that other FAD-linked APP, PS1, and PS2 mutations selectively increase A42.”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
In the citing paper
“In that report, we suggested that cerebral A deposition in FAD occurs because of an increase in CNS A that develops as part of a generalized genetic effect that also increases plasma A.”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citationCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Self-citationCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Self-citationJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Self-citationJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCitron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Self-citationIsolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Self-citation
Cited by
Items 2,301–2,400 of 2,576
Studies on -secretase activity and products
Frånberg, J. (2010) · Figshare
Neurobiologic Basis of Age-Related Dementing Disorders
Hof, P. R., Bussière, T., Buxbaum, J. D., & Morrison, J. H. (2006) · Springer eBooks · doi:10.1007/0-387-22621-4_76
Characterization of a novel interaction between presenilin-1 and monoamine oxidase-A
Gabriel, G. G. (2008) · University Library - University of Saskatchewan (University of Saskatchewan)
Chapter 3 Noncovalent Protein Interactions
Bernstein, S. L., & Bowers, M. T. (2008) · Comprehensive analytical chemistry · doi:10.1016/s0166-526x(08)00203-1
Jonghe, C. D., & Broeckhoven, C. V. (1999) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(99)80063-7
In vitro modelling of tau phosphorylating kinases : emphasis of Cdk5
Jämsä, A. (2007) · Figshare · Cited by 2
Molecular genetics of Alzheimer's disease and other adult-onset dementias
George‐Hyslop, P. S. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.030
Molecular and cell biological aspects of Alzheimer's ß-amyloid precursor and related proteins
van den Hurk, W. H. (2001) · Radboud Repository (Radboud University)
Presenilin-1 Immunoreactivity in Human Neurodegenerative Diseases
Giannakopoulos, P., K�vari, E., Canuto, A., Hof, P. R., & Bouras, C. (1999) · KARGER eBooks · doi:10.1159/000061433
Perturbed calcium homeostasis in neurodegenerative disorders
Mattson, M. P. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)07015-8
Amyloid β-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease
Sundelöf, J. E. (2010) · Uppsala University Publications (Uppsala University)
Immunosignature of Alzheimer's Disease
Jimenez, L. R. (2011)
Endosomes élargis et cholestérol : De la trisomie 21 à la maladie d'Alzheimer
Cossec, J. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Öztürk, A. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Haass, C. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57092-6_20
Genetics of early-onset Alzheimer disease
George‐Hyslop, P. S. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8225-5_18
Towards a Molecular Classification of Neurodegenerative Disease
Hardy, J. (2005) · Research and perspectives in Alzheimer's disease · doi:10.1007/3-540-26522-8_2
Self-citationThe Cellular Biology of Presenilin Proteins and a Novel Mechanism of Amyloid β-Peptide Generation
Haass, C., Walter, J., Capell, A., Wild‐Bode, C., Grünberg, J., Yamazaki, T., Ihara, I., Zweckbronner, I., Jakubek, C., & Baumeister, R. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_8
Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer’s Disease
Papassotiropoulos, A., Maddalena, A. S., Gretener, D. C., Nitsch, R. M., & Höck, C. (2004) · Springer eBooks · doi:10.1007/978-3-642-59300-0_2
Neural networks in a mouse model of amyloid pathology
Palmer, A. M. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Pathogenic mechanisms of the Arctic Alzheimer mutation.
Sahlin, C. (2007) · Uppsala University Publications (Uppsala University)
Genetic Basis of Resistance to Alzheimer’s Disease and Related Neurodegenerative Diseases
Masters, C. L., & Beyreuther, K. T. (2000) · Springer eBooks · doi:10.1007/978-3-642-56947-0_11
The Biological Basis of Dementias
Racchi, M., & Govoni, S. M. (1999) · Springer eBooks · doi:10.1007/978-88-470-2149-5_2
A Brief Introduction to the History of the β-Amyloid Protein (Aβ) of Alzheimer’s Disease
Small, D. H., & Barrow, C. J. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_1 · Cited by 1
“All of these mutations have been found to cluster around the Αβ sequence, and all of them have so far been shown to directly or indirectly cause an increase in forms of Αβ that aggregate [25].”
BackgroundDorman, H., Meschino, W. S., Allanson, J. E., Blaine, S., Cremin, C., Gibbons, C., Honeywell, C. R., Permaul, J., & Carroll, J. C. (2009) · PubMed Central
Transgenic Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease
Wong, P. C., Borchelt, D., Lee, M. K., Thinakaran, G., Sisodia, S. S., & Price, D. L. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50008-7
Transgenic Approaches to the Study of Alzheimer’s Disease
Duff, K. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_11
Balasa, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Therapeutic Opportunities in Alzheimer Disease: Current Concepts
Marlatt, M. W., Moreira, P. I., Lee, H., Casadesús, G., Castellani, R. J., Takeda, A., Nunomura, A., Zhu, X., Perry, G. L., & Smith, M. A. (2010) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805207310904010767
A Novel Gene in the Armadillo Family Interacts with Presenilin 1
Kosik, K. S., Ho, C., Liyange, U., Lemere, C. A., Medina, M., & Zhou, J. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50013-0
Shu, H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.003
Reduction of choline acetyltransferase activities inAPP 770 transgenic mice
Li, H. (2000) · Chinese Science Bulletin · doi:10.1007/bf02887413
Hall, K. (2011) · ORCA Online Research @Cardiff (Cardiff University)
Introspective Analysis of Amyloid as the Cause of Alzheimer‘s Disease: Alternative Model Proposed
LeBlanc, A. C. (2008) · Future Neurology · doi:10.2217/14796708.3.5.527
“• Genetic mutations in the APP, presenilin 1 (PSEN 1) and presenilin 2 (PSEN 2) genes that are associated with familial AD cause an increase in Aβ production [17–19] or aggregation [20];”
BackgroundThe implications of genetic studies on the pathogenesis of Alzheimer's disease
Sasaki, H. (1998) · Neuropathology · doi:10.1111/j.1440-1789.1998.tb00086.x
Delacourte, A., Campion, D., & Davous, P. (2007) · EMC - Neurologia · doi:10.1016/s1634-7072(07)70544-5 · Cited by 2
Merlin, J. L. P. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.3.125
Ritchie, A. (2004) · Nottingham ePrints (University of Nottingham)
Quantitative Analysis of Presenilin‐1 mRNA Expression in Sporadic Alzheimer's Disease Brain
Baba, H., Ohnuma, T., Shibata, N., Takahashi, T., & Arai, H. (2001) · Psychogeriatrics · doi:10.1111/j.1479-8301.2001.tb00051.x · Cited by 1
Apolipoproteins and β Amyloid Transport Pathway
Kamino, K., Kida, T., Tanaka, T., Tanii, H., Okochi, M., Kudo, T., Kobayashi, T., & Takeda, M. (2002) · Psychogeriatrics · doi:10.1111/j.1479-8301.2002.tb00078.x
Determinants of Cognitive Decline and Dementia in the Very Old
Euser, S. M. (2008) · RePub (Erasmus University Rotterdam)
Resolution of inflammation in Alzheimer’s disease
Wang, X. (2014) · Figshare
Recent Alzheimer's disease research highlights
Galasko, D. R., Golde, T. E., & Wilcock, G. K. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt117
Weber, C. (2010) · University of Vienna · doi:10.25365/thesis.8628
Biomarkers for Alzheimer’s Disease and Parkinson’s Disease
Growdon, J. H., Irizarry, M. C., & Scherzer, C. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_16
SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID
Handoko, M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Lain, E. (2004) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Characterization of the Alzheimer´s disease-associated clac protein
Söderberg, L. (2005) · Figshare
Early conformational changes control spontaneous polyQ-mediated huntingtin polymerization
Wagner, A. S. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8800 · Cited by 1
Tran, H. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7gb223z · Cited by 3
“Virtually all 7 mutations in APP, PS1 and PS2 result in increase Aβ production, in particular the Aβ isoform which has 42 amino acids (Citron et al., 1992; Citron et al., 1994; Haass et al., 1994; Lemere et al., 1996b; Mann et al., 1996; Scheuner et al., 1996; Citron et al., 1997).”
BackgroundNeuroprotective Effect of Genistein : Studies in Rat Models of Parkinson’s and Alzheimer’s Disease
Bagheri, M. (2012) · DiVA (Linkoping University) · Cited by 2
Long-term neuropsychological outcome following subarachnoid haemorrhage or traumatic brain injury
Morris, P. G. (2001) · Stirling Online Research Repository (University of Stirling)
Costa, D. A. (2005) · Digital Commons - University of South Florida (University of South Florida)
Organische psychische Störungen
Kurz, A. (2006) · Springer eBooks · doi:10.1007/3-540-27385-9_164
Amyloid-β Protofibrils in Alzheimer´s Disease : Focus on Antibodies, Inflammation and Astrocytes
Söllvander, S. (2015) · Uppsala University Publications (Uppsala University)
Sobów, T., Flirski, M., & Liberski, P. P. (2007)
Sambamurti, K., Padmaraju, V., Mintzer, J. E., Bachman, D., Granholm, A., Greig, N. H., & Pappolla, M. A. (2012)
RADIOLABELLED THIOFLAVIN-T DERIVATIVES VO DIAGNOSIS OF PERIPH
Wetenschappen, F. F. (2004)
Pathological Changes in Neurodegenerative Disease
Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_3
TRAFFICKING OF α-SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION
Farmacologiche, S., Farmacia, F. D., Farmacotossicologiche, S., & Ciclo, X. (2011)
Genetic and Expressional Studies of Alzheimer's Disease
Iivonen, S. (2005)
Langer, U., Albrecht, C., Mayhaus, M., Velden, J., Wiegmann, H., Klaudiny, J., Müller, D., von der Kammer, H., & Nitsch, R. M. (1998) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-72103-8_9
Other Genes Implicated in Alzheimer’s Disease
Carrasquillo, M. M., Allen, M., & Ertekin‐Taner, N. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_12
Alternative Endoproteolysis of the Presenilins and Familial Alzheimer’s Disease
Tanzi, R. E., Kim, T.-W., Kovacs, D. M., Wasco, W., Moir, R. D., Pettingell, W. H., Henderson, J., & Mancini, R. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_3
“Plasma and fibroblasts from patients and at-risk carriers with the presenilin mutations have been shown to contain increased amounts of a longer, more amyloidogenic form of the AB peptide, ABx-42 (Scheuner et al. 1996).”
BackgroundSelf-citationIMMUNOTHERAPY IN COMBINATION WITH BEHAVIORAL ENRICHMENT IN A CANINE MODEL OF AGING
Davis, P. R. (2014) · UKnowledge (University of Kentucky)
The Rho GTPases Rac1, Cdc42, and RhoA Regulate APP Transport to Lysosomes and Aβ Production
Chiu, & Justin, K. (2015) · Scholarship@Western (Western University)
Duff, K. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_7
Aβ Conformation Dependent Antibodies and Alzheimer's Disease
Sehlin, D. (2010) · Uppsala University Publications (Uppsala University)
Bartley, M. G. (2010) · Digital Commons - DU (University of Denver)
PLEIOTROPIC MECHANISMS OF STATIN ACTION IN ALZHEIMER'S DISEASE
Ostrowski, S. M. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Genetic Risk Factors for Neurodegenerative Diseases
Inoue, K. (2015) · Springer eBooks · doi:10.1007/978-4-431-54541-5_6 · Cited by 1
Translational Approaches in Alzheimer’s Disease
Wood, S. J., & Vargas, G. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803460-6.00007-6 · Cited by 1
Review Alzheimer ß-amyloid peptides: normal and abnormal localization
Edgar, M. A., & Gouras, G. K. (2002)
Functional implications of tau-fyn interactions in Alzheimer's disease
Lau, H. W. D. (2015)
Functional Implications of Domain Organization Within Prokaryotic Rhomboid Proteases
Panigrahi, R., & Lemieux, M. J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-23603-2_6
Mass Spectrometry-Based Investigation of APP-Dependent Mechanisms in Neurodegeneration
Chaput, D. (2015) · Digital Commons - University of South Florida (University of South Florida)
Neuropathologie de la maladie d'Alzheimer
Bouras, C., Savioz, A., Kövari, E., Vallet, P. G., Michon, A., & Hof, P.-R. (2004) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(01)00050-5 · Cited by 1
Pathogenesis of Alzheimer's Disease with Special Reference to Amyloid β Protein
Tamaoka, A. (2012) · Nihon Ika Daigaku Igakkai Zasshi · doi:10.1272/manms.8.285 · Cited by 1
Physiopathologie de la maladie d'Alzheimer
Delacourte, A. (2006) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(06)75448-5 · Cited by 2
Racchi, M., Gasparini, L., Trabucchi, M., & Govoni, S. M. (1997) · Aging Clinical and Experimental Research · doi:10.1007/bf03339707
Imaging mouse models of neurodegeneration using multi-parametric MRI
Holmes, H. (2015) · UCL Discovery (University College London)
Chapter 4. Transgenic Mice Overexpressing GSK-3 β as Animal Models for Alzheimer's Disease
Hernández, F. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732758-00052
der Fakultät, D., & München, L.-M.-U. (2008)
Interaction of the Presenilins with the Amyloid Precursor Protein (APP)
Weidemann, A., Paliga, K., Dürrwang, U., Reinhard, F. B. M., Zhang, D., Sandbrink, R., Evin, G. M., Masters, C. L., & Beyreuther, K. T. (2003) · Humana Press eBooks · doi:10.1385/1-59259-195-7:333
The Complex Pathways to Mechanism-Based Therapeutics in Alzheimer’s Disease
Selkoe, D. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00001-0
Self-citationMuscarinic Modulation of β-Amyloid Precursor Protein (βApp) Processing in Vitro and in Vivo
Pittel, Z., Eshhar, N., Heldman, E., Sapir, M., Haring, R., Kushnir, M., & Fisher, A. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_73
Amyloid-β Protofibril Formation and Neurotoxicity : Implications for Alzheimer’s Disease
Johansson, A. (2007) · Uppsala University Publications (Uppsala University) · Cited by 1
Golde, T. E., Lessard, C. B., & Ran, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00005-8
double mutant knock-in mice model of Alzheimer disease as a function of age
Sultana, R., Abdul, H. M., Markesbery, W. R., Cai, J., Pierce, W. M. J., & Allan, D. (2011)
The iPSC Technology to Study Neurodevelopmental Disorders
Muotri, A. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00018-2
Genetics and Neurobiology of Alzheimer’s Disease and Frontotemporal Dementias
George‐Hyslop, P. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_118
Transgenic mouse models of Alzheimer's disease
Brooks, S. P., & Dunnett, S. B. (2005) · CRC Press eBooks · doi:10.1201/b13239-71
Biochemical Characterization of Amyloid Precursor Protein
Xia, W. (2004) · CRC Press eBooks · doi:10.1201/9780203492185.ch1
Active Immunization Against the Amyloid-β Peptide
Liu, E., & Ryan, J. M. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_2
Metadata
- Authors
- Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, L., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., & Younkin, S.
- Affiliations
- Case Western Reserve University (US)
- Mayo Clinic (US)
- Karolinska Institutet (SE)
- Brigham and Women's Hospital (US)
- Takeda (Japan) (JP)
- University of Washington (US)
- University of South Florida (US)
- Harvard University (US)
- ORCID
- Venue
- Nature Medicine
- Published
- 1996-08
- Volume
- 2
- Issue
- 8
- Pages
- 864-870
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101077392
- Semantic Scholar
- ce2164647cb7fb8dcec21d95359a92ec9830047a
- Cited by
- 2,599
- References
- 40
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 58 · 2023: 74 · 2022: 45 · 2021: 66 · 2020: 66 · 2019: 58 · 2018: 53 · 2017: 64 · 2016: 76 · 2015: 72 · 2014: 77 · 2013: 91 · 2012: 96
- FWCI
- 102.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, familial Alzheimer's disease, presenilin 1, presenilin 2, amyloid precursor protein, APP mutations, amyloid plaques
- MeSH terms
- Alzheimer Disease, Cells, Cultured, Female, Fibroblasts, Humans, Male, Membrane Proteins, Mutation, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Culture Media, Conditioned, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.